2-Amino-7-(4-fluoro-phenyl)-4-methyl-7,8-dihydro-6H-quinazolin-5-one → 2-Amino-7-(2-methoxy-phenyl)-4-methyl-7,8-dihydro-6H-quinazolin-5-one
Reaktionsgleichung
[C:1]([CH:4]1[C:9](=[O:10])[CH2:8][CH:7]([C:11]2[CH:16]=[CH:15][CH:14]=[CH:13][C:12]=2[O:17][CH3:18])[CH2:6][C:5]1=O)(=O)[CH3:2].[NH2:20][C:21]1[N:30]=C(C)C2C(=O)CC(C3C=CC(F)=CC=3)CC=2[N:22]=1>>[NH2:30][C:21]1[N:22]=[C:1]([CH3:2])[C:4]2[C:9](=[O:10])[CH2:8][CH:7]([C:11]3[CH:16]=[CH:15][CH:14]=[CH:13][C:12]=3[O:17][CH3:18])[CH2:6][C:5]=2[N:20]=1Komponenten
3
Versuchsvorschrift
The title compound was prepared from 2-acetyl-5-(2-methoxy-phenyl)-cyclohexane-1,3-dione (872 mg, 3.35 mmol), from stage 1, following the procedure describing the synthesis of 2-amino-7-(4-fluoro-phenyl)-4-methyl-7,8-dihydro-6H-quinazolin-5-one (example 3/a stage 2/3) except that the title compound was further purified by recrystallisation in methanol.
Aufarbeitung
- customwas further purified by recrystallisation in methanol
Quellen und Nachweise
- ORD-Eintrag
- ord-4ee409a49aab4f098ee2bb749a4387e7
- Quelldatensatz
- uspto-grants-2013_11
- Patentnummer
- US08592430B2
Notizen zur Reaktion
Wird geladen…